In T2D, the disease is driven by an interplay between insulin resistance and β‐cell dysfunction in genetically susceptible individuals, with metabolic stress and perhaps also inflammation impairing insulin secretion and eventually β‐cell survival, although to a less degree than in T1D.1, 4, 5. The gene discussed is INS; the disease is type 2 diabetes mellitus.